Eurovestech Share Discussion Threads

[rambutan2] 08/9/2005 23:06

here here!

[kenmitch] 08/9/2005 20:20

Excellent Toluna news today.

ADVFN competitor.uk-wire.com/cgi-bin/articles/20050908082658P5DBB.html

Toluna shares are up over 4p today to 80.50 - they floated at 70p. So the value of the EVT Toluna stake continues to increase.Toluna anticipates announcing excellent results. What more can investors want? With hindsight maybe I should have bought some Toluna shares rather than more EVT. But it is EVT that looks at a bargain price now.

Not a shred of interest anywhere. Nothing here - or anywhere else as far as I can see. EVT shares were unchanged today on the news. Just as they only ticked up 0.25p on the excellent KSS news a few weeks ago. KSS alone could be worth more than the entire EVT market cap with the increasing value of their Toluna stake and everything else in for nothing.

When will investors cotton on to EVT? The shares look a real bargain as the Company continues to do everything right. ONE day - surely not before too much longer - the shares are going to go up a lot and those of us with patience will be well rewarded imho.

[kenmitch] 02/9/2005 14:53

Toluna up another 1p - someone has bought a few!

So EVT goes down 0.25p.

One day people will cotton on to EVT - but it seems to be taking a long time.

Results later this month?

Maybe these will do the trick at last. Always assuming the news/figures are good.

[agnes] 12/8/2005 07:45

Comment on yesterday's news


Eurovestech shares added 0.5p to 12.5p after the company revealed that Knowledge Support Systems (KSS), a wholly-owned portfolio company, produced post-tax profits of more than 950,000 pounds. Turnover at KSS, which is a leading pricing solutions provider for the retail and petroleum industries, increased to more than 5 million pounds. Meanwhile, with the sales and profits momentum continuing at KSS, investors speculated that the this one investment alone could potentially be worth substantially more than its holding company.

[bitterlemontart] 11/8/2005 08:36

UK smallcap opening - Eurovestech ticks up on Knowledge Support numbers

LONDON (AFX) - Eurovestech ticked up 1/2 to 12-1/2 pence after the company
revealed that Knowledge Support Systems (KSS), a wholly-owned portfolio company,
produced a profit after tax in excess of 950,000 stg in the year ended June 27
2005.
This compares to a loss for the previous year of 2.6 mln stg.
Turnover at KSS, which is a leading provider of pricing solutions to retail
and petroleum industries, increased to more than 5 mln stg, against 1.2 mln the
previous year.
Additionally, in recent weeks, KSS has reached agreement with several global
retailers to commence trials in the US and Europe and this activity augurs well
for prospects in the current financial year, Eurovestech said.

[bitterlemontart] 11/8/2005 08:30

Eurovestech says Knowledge Support Systems moves into profit at FY

LONDON (AFX) - Eurovestech PLC said Knowledge Support Systems Ltd ("KSS"), a
wholly-owned portfolio company, produced a profit after tax in excess of 950,000
stg in the year ended June 27 2005.
This compares to a loss for the previous year of 2.6 mln stg.
It said turnover at KSS, which is a leading provider of pricing solutions to
retail and petroleum industries, increased to more than 5 mln stg, against 1.2
mln the previous year.
Additionally, in recent weeks, KSS has reached agreement with several global
retailers to commence trials in the US and Europe and this activity augurs well
for prospects in the current financial year, Eurovestech added.

[e-mail]

[sandbank] 11/8/2005 08:23

I am a bit foggy as to what KSS does. What are pricing solutions? Why should an oil company pay money to KSS to find out at what price to pitch their petrol when all they need do is check what price the nearest petrol station is selling at? The presence of BP and Conoco on their client list suggests there is some rationale behind it ...but what?

[bitterlemontart] 11/8/2005 08:10

Nice one !

[lyceeuk] 11/8/2005 07:12

Trading Statement

11 August, 2005

Eurovestech plc ("Eurovestech")

Knowledge Support Systems Limited ("KSS") Trading Update

Eurovestech is pleased to report that KSS, a wholly-owned portfolio company,
produced a profit after tax in excess of ?950,000 in the year ended 27 June,
2005. This compares to a loss for the previous year of ?2.6 million. Turnover
at KSS, which is a leading provider of pricing solutions to retail and
petroleum industries, increased to more than ?5 million, against ?1.2 million
the previous year.

Additionally, in recent weeks, KSS has reached agreement with several global
retailers to commence trials in the US and Europe and this activity augurs well
for prospects in the current financial year.

Richard Bernstein, Chief Executive of Eurovestech said: "The achievement of
full-year profitability, combined with a more than four-fold increase in sales,
is an important milestone for KSS. Moreover, both the range and the quality of
recent customer wins provide great confidence in the outlook for the business."

Further enquiries:

Eurovestech plc

Richard Bernstein Telephone: [phone]

Chief Executive



END

[bitterlemontart] 24/7/2005 18:55

My share price target = 25p +....

[bitterlemontart] 24/7/2005 18:31

• Midas verdict: Putting money into a company that invests in technology-driven firms is not for the fainthearted. But Eurovestech's management has shown it can deliver.

T&G reckons the theoretical net asset value is 14.1p - a 20% premium to the current share price. Highly respected Invesco Perpetual fund manager Neil Woodford holds 11%, which also inspires confidence. A speculative buy.

[kenmitch] 24/7/2005 13:48

EVT tipped today apparently in The Mail on Sunday. Spotted it on page 502 teletext Channel 4. Maybe someone else can post a link or the exact details? I presume it is in the Midas tipping column? Presumably the share price will be marked up a bit tomorrow.

[kenmitch] 18/7/2005 19:59

Some chunky trades going through over the last few days. More than 1 million today, admittedly some are sells. Interesting. Can't understand why the shares have not moved up - yet - on endless good news. Possibly because so few - other than some here - seem to follow this share. A hidden gem imo - but surely soon the progress is going to get noticed and reflected in a rising share price?

[pensionfund] 14/7/2005 14:33

With all the good news from EVT recently a nice set of end of year accounts in Spetember should see some significant upwards movement of this share price.

[lord orphan] 13/7/2005 12:13

Well spotted ram. EVT has only 0.23% which it paid $165k for, so it doesn't appear to be that material. If it was a huge float I don't think Seymour Pierce would be acting.

[lord orphan] 30/6/2005 11:15

Teather & Greenwood note raised the "theoretical NAV" to 14.1p and upgraded recommendation to strong buy.

[kenmitch] 31/5/2005 13:20

Two trades in Toluna shares today - both look like buys, one a significant 140,000 trade.

Has there been anything about Toluna in The Press?

[rambutan2] 25/5/2005 11:48

evt has promised to hold onto all its shares for a year.

[lord orphan] 25/5/2005 11:42

TOL quoted at 71-75. Volume nil

[rambutan2] 25/5/2005 09:23

here we go...
TOLUNA PLC

ANNOUNCEMENT OF ADMISSION TO AIM AND COMMENCEMENT OF DEALINGS

ToLuna plc (TOL) ('ToLuna', 'Group' or the 'Company'), a provider of online solutions and services to corporations and the market research industry, today announces the admission of its ordinary shares to the Alternative Investment Market ('AIM') and the commencement of dealing in its shares.

On behalf of the Company, Cenkos Securities Limited has placed 7,142,857 shares
at a placing price of 70p per share, to raise £4.4 million (net of expenses),
representing 19.97 per cent. of the enlarged issued share capital. At the
placing price of 70p, the Company has a market capitalisation of £25.04 million.

In addition, on behalf of Frederic-Charles Petit, Chief Executive of ToLuna,
Cenkos Securities Limited has placed 857,143 shares at the same price to raise
£0.6 million, representing 2.40 per cent. of the enlarged issued share capital.
Following the placing Frederic-Charles Petit now holds 14.1 per cent. of the
enlarged issued share capital of the Company.

At Admission Eurovestech plc hold 63.5 per cent. of the enlarged issued share
capital of the Company.

[kenmitch] 20/5/2005 14:15

Agreed re DPharm of course, and on the big 3 - though others in the portfolio could well be worth very useful amounts too even allowing for the smaller EVT stakes in those.

Hope you're right about the £100 million!

You're surely right about the share price. The shares were around this price a year ago - and just look at the great newsflow since then.

Now all eyes will be on what happens to the Toluna share price (if anything) when they start trading on Wednesday.

IF the Institutions who have invested maintain their tradition of solid long term support for EVT then there shouldn't be too much selling -and maybe it won't take much buying to lift the price?

Whatever. EVT has been a wonderful investment for those of us who were posting and buying when the shares were around 2p for ages, and in time with further positive newsflow likely there should be much more to come.

This is a Company that delivers - all that is required by investors is patience. So EVT does not appeal to the get rich quick brigade who seem to be in the large majority when it comes to investing in small companies. They of course take no interest in EVT - which is their loss imo!

[lord orphan] 18/5/2005 10:47

D-Pharm is a tiny investment - 0.23% of the equity acquired for $165,000. It would have to be worth billions to make any difference to EVT. The big 3 are ToLuna, KSS and Magenta which could be worth close to £100m on exit. The shares are definitely worth more than 11.5p.

[rambutan2] 15/5/2005 15:11

agree kenmitch, im an ex pdt shareholder having finally had enough of the management's inability to get shareholder value.

yes, i mean d-pharma, where did i get france from! and now im doubting my float rumour!!

Red Herring selects D-Pharm as a Top 100 European company.

Rehovot, Israel, April 12, 2005 -- D-Pharm Ltd., announced today that it has won an award as one of Red Herring's top 100 private European companies. D-Pharm was selected from over 800 candidates as one of the most exciting European companies that have the potential to impact current markets or create entirely new markets. The Red Herring award is only presented to companies having products and services that define the future of business innovation.

D-Pharm is a biopharmaceutical company developing innovative drugs to treat CNS disorders such as stroke, epilepsy and Alzheimer's disease (AD) and has two lead programs in Phase II studies.

"D-Pharm is delighted to receive this prestigious award from Red Herring. The award recognises the unique potential of our proprietary technology to generate a rich pipeline. of innovative drugs to treat major medical needs," said D-Pharm's CEO Dr. Alex Kozak. "The Red Herring Forum exposes D-Pharm to both future funding sources and potential strategic partnerships, both invaluable to a fast growing company."

Brian Berman, CFO of D-Pharm will accept the award and present the company's business model and technology at the Red Herring Venture Market Europe 2005 conference in London on Wednesday, April 13th (see - www.redherring.com/events).